232 related articles for article (PubMed ID: 24824398)
1. [Advances in immunotherapy for pediatric cancer].
Xu X; Zhao H; Tang Y
Zhonghua Er Ke Za Zhi; 2014 Mar; 52(3):231-4. PubMed ID: 24824398
[No Abstract] [Full Text] [Related]
2. [Cancer immunotherapy].
Vakkila J; Pihkala U
Duodecim; 1999; 115(7):785-94. PubMed ID: 11859512
[No Abstract] [Full Text] [Related]
3. Targeting Innate Immune Cells for Immunotherapy.
Carreño LJ; Prados-Rosales R; López M; Baena A; González PA
J Immunol Res; 2017; 2017():4271384. PubMed ID: 28480223
[No Abstract] [Full Text] [Related]
4. [New era of tumor immunotherapy].
Yoshitake Y; Nakatsura T; Nishimura Y
Nihon Rinsho; 2005 Apr; 63 Suppl 4():46-55. PubMed ID: 15861634
[No Abstract] [Full Text] [Related]
5. Cellular and Antibody Based Approaches for Pediatric Cancer Immunotherapy.
Huang MA; Krishnadas DK; Lucas KG
J Immunol Res; 2015; 2015():675269. PubMed ID: 26587548
[TBL] [Abstract][Full Text] [Related]
6. Cancer Immunotherapy: Theory and Application.
Chen G; Bodogai M; Tamehiro N; Shen C; Dou J
J Immunol Res; 2018; 2018():7502161. PubMed ID: 30035133
[No Abstract] [Full Text] [Related]
7. Promising immunotherapy technique.
Fillon M
J Natl Cancer Inst; 2012 Oct; 104(20):1528-9. PubMed ID: 23044382
[No Abstract] [Full Text] [Related]
8. Cancer immunotherapy: will expanding knowledge lead to success in pediatric oncology?
Fry TJ; Lankester AC
Pediatr Clin North Am; 2008 Feb; 55(1):147-67, xi. PubMed ID: 18242319
[TBL] [Abstract][Full Text] [Related]
9. The evolving clinical landscape for dendritic cell vaccines and cancer immunotherapy.
Cannon MJ; Block MS; Morehead LC; Knutson KL
Immunotherapy; 2019 Feb; 11(2):75-79. PubMed ID: 30730268
[No Abstract] [Full Text] [Related]
10. Human Tumor Antigens and Cancer Immunotherapy.
Vigneron N
Biomed Res Int; 2015; 2015():948501. PubMed ID: 26161423
[TBL] [Abstract][Full Text] [Related]
11. A power surge for cancer immunotherapy: antibodies, vaccines, and engineered T cells fuel new optimism.
Nelson B
Cancer Cytopathol; 2014 Jan; 122(1):1-2. PubMed ID: 24424750
[No Abstract] [Full Text] [Related]
12. Cancer vaccines: progress reveals new complexities.
Yu Z; Restifo NP
J Clin Invest; 2002 Aug; 110(3):289-94. PubMed ID: 12163445
[No Abstract] [Full Text] [Related]
13. [New strategies in cancer immunotherapy].
Ruan RS; Xu KC
Zhonghua Zhong Liu Za Zhi; 2011 Dec; 33(12):943-6. PubMed ID: 22340107
[No Abstract] [Full Text] [Related]
14. Exploiting dendritic cells and natural killer T cells in immunotherapy against malignancies.
Fujii S
Trends Immunol; 2008 May; 29(5):242-9. PubMed ID: 18372215
[TBL] [Abstract][Full Text] [Related]
15. [Oncoimmunology: some fundamental problems of cancer immunotherapy].
Nedospasov SA; Kuprash DV
Mol Biol (Mosk); 2007; 41(2):355-68. PubMed ID: 17514902
[TBL] [Abstract][Full Text] [Related]
16. Natural killer T cell-based cancer immunotherapy.
van der Vliet HJ; Balk SP; Exley MA
Clin Cancer Res; 2006 Oct; 12(20 Pt 1):5921-3. PubMed ID: 17062661
[No Abstract] [Full Text] [Related]
17. Cancer vaccines: the state of the art.
Finn OO; Banchereau J
Semin Immunol; 2010 Jun; 22(3):103-4. PubMed ID: 20552730
[No Abstract] [Full Text] [Related]
18. Genetically modified dendritic cells in cancer immunotherapy: a better tomorrow?
Shurin MR; Gregory M; Morris JC; Malyguine AM
Expert Opin Biol Ther; 2010 Nov; 10(11):1539-53. PubMed ID: 20955111
[TBL] [Abstract][Full Text] [Related]
19. [Immunotherapy for cancer--modern immunologic strategies in oncology].
Halama N; Zoernig I; Jäger D
Dtsch Med Wochenschr; 2008 Oct; 133(41):2105-8. PubMed ID: 18985564
[TBL] [Abstract][Full Text] [Related]
20. An introduction to tumour immunology.
Keith J
Mater Med Pol; 1984; 16(1):54-64. PubMed ID: 6394909
[No Abstract] [Full Text] [Related]
[Next] [New Search]
